+++ deriBX - Der neue und innovative Handelsplatz der BX Swiss. Mehr erfahren! +++ -w-
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
15.10.2019 15:00:00

Better Buy: GlaxoSmithKline vs. Merck

Healthcare is big business, and investors looking for stable, long-term growth stocks should look no further than Merck & Co. (NYSE: MRK) and GlaxoSmithKline (NYSE: GSK). Both are significant players in the pharmaceutical industry, and both companies offer investors some great investment options with low volatility that pay dividends.Let's take a closer look to see which of these is the better option today.Despite showing some impressive growth in its most recent quarter, Merck's share price has risen just 10% in 2019. It has been carried in part by the strong success of Keytruda, a cancer-fighting drug that could be integral to the company's long-term success. With Keytruda improving the survival rate of patients suffering from lung cancer, there's a lot of potential to help Merck generate even more success in the years to come, especially as it receives approval to use Keytruda for more treatment options. Most recently, the U.S. Food and Drug Administration gave it the OK for treating certain types of melanoma.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

(Anzeige)Passende emittierte Barrier Reverse Convertibles

Basiswert Valor Fälligkeitstag Maximale Rendite p.a.
Bristol-Myers Squibb Co. / Eli Lilly & Co. / GlaxoSmithKline Plc. / Merck & Co. Inc. 41253561 26.01.2021 4.91 %

Analysen zu Merck Co.mehr Analysen

29.10.19 Merck Neutral Goldman Sachs Group Inc.
30.09.19 Merck Neutral JP Morgan Chase & Co.
25.01.19 Merck Market Perform BMO Capital Markets
25.10.18 Merck Conviction Buy List Goldman Sachs Group Inc.
23.04.18 Merck buy Goldman Sachs Group Inc.

Eintrag hinzufügen

SMI im Aufwind – Saudi Aramco vor IPO | BX Swiss TV

Aktien in diesem Artikel

Finanzen.net News

pagehit
FinanzenNet.Finando.Web.Core.Areas.Article.ViewModels.News.DetailsViewModel FinanzenNet.Finando.Web.Core.Extensions.VueComponent ;